1
/
of
1
Medical Education Hub
Keck USC The USC Peter A. Singer Thyroid Symposium 2021
Keck USC The USC Peter A. Singer Thyroid Symposium 2021
Regular price
€10,00 EUR
Regular price
Sale price
€10,00 EUR
Taxes included.
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
Keck USC The USC Peter A. Singer Thyroid Symposium 2021
+ Target Audience: endocrinologists, primary care providers, hhead and neck surgeons, endocrine surgeons + Information:Date & Location
Saturday, June 5, 2021, 7:30 AM – 1:15 PM, USC Health Sciences Campus, Los Angeles, CA
Overview
Continuing the tradition of dedication to providing a comprehensive and current update in the management of thyroid disease, USC presents Virtual Thyroid The USC Peter A. Singer Thyroid Symposium in 2021. Throughout its history, this symposium has sought to educate and foster enthusiasm about thyroid care in an increasingly complex and evolving field.
The program presents forward-looking perspectives representing the most current state of thyroid medicine and what the future is likely to hold. Clinical care of patients with thyroid disorders is increasingly complex and informed by evidenced-based management strategies. New options now abound for many important thyroid conditions.
For 2021, the program takes on areas of recent advancement and current debate, including the long-term management of hyperthyroidism, thyroid emergencies, pre-pregnancy management, thyroid cancer management, and alternative thyroid hormone replacements.
Presentations combining evidence-based medicine and clinical experience, challenging cases, and panel discussions from audience questions will help inform practice decisions in an era of complex clinical problems.
Objectives
- Develop an approach to perplexing thyroid function test results.
- Diagnose and treat thyroid emergencies.
- Provide preconception counseling to the thyroid patient desiring pregnancy.
- Appreciate new data beyond the guideline-based management of thyroid cancers.
- Utilize thyroglobulin measurement in the management of thyroid cancer.
- Examine alternative thyroid hormone replacement other than levothyroxine.
- Provide a clinical update on the treatment of hyperthyroidism.
- Evaluate the data regarding thyroid cancer and obesity.
Share
